Literature DB >> 25425683

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.

Anna M Aalbers1, Marry M van den Heuvel-Eibrink2, Irith Baumann3, Michael Dworzak4, Henrik Hasle5, Franco Locatelli6, Barbara De Moerloose7, Markus Schmugge8, Ester Mejstrikova9, Michaela Nováková9, Marco Zecca10, C Michel Zwaan2, Jeroen G Te Marvelde11, Anton W Langerak11, Jacques J M van Dongen11, Rob Pieters2, Charlotte M Niemeyer12, Vincent H J van der Velden13.   

Abstract

Refractory cytopenia of childhood is the most common type of childhood myelodysplastic syndrome. Because the majority of children with refractory cytopenia have a normal karyotype and a hypocellular bone marrow, differentiating refractory cytopenia from the immune-mediated bone marrow failure syndrome (very) severe aplastic anemia can be challenging. Flow cytometric immunophenotyping of bone marrow has been shown to be a valuable diagnostic tool in differentiating myelodysplastic syndrome from non-clonal cytopenias in adults. Here, we performed the first comprehensive flow cytometric analysis of immature myeloid, lymphoid cells and erythroid cells, and granulocytes, monocytes, and lymphoid cells in bone marrow obtained from a large prospective cohort of 81 children with refractory cytopenia. Children with refractory cyotopenia had a strongly reduced myeloid compartment, but not as severe as children with aplastic anemia. Furthermore, the number of flow cytometric abnormalities was significantly higher in children with refractory cytopenia than in healthy controls and in children with aplastic anemia, but lower than in advanced myelodysplastic syndrome. We conclude that flow cytometric immunophenotyping could be a relevant addition to histopathology in the diagnosis of refractory cytopenia of childhood. (The multi-center studies EWOG-MDS RC06 and EWOG-MDS 2006 are registered at clinicaltrials.gov identifiers 00499070 and 00662090, respectively). Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25425683      PMCID: PMC4349269          DOI: 10.3324/haematol.2014.107706

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  47 in total

1.  Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.

Authors:  Katherine R Calvo; Donald C Vinh; Irina Maric; Weixin Wang; Pierre Noel; Maryalice Stetler-Stevenson; Diane C Arthur; Mark Raffeld; Amalia Dutra; Evgenia Pak; Kyungjae Myung; Amy P Hsu; Dennis D Hickstein; Stefania Pittaluga; Steven M Holland
Journal:  Haematologica       Date:  2011-04-20       Impact factor: 9.941

2.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Authors:  Amy P Hsu; Elizabeth P Sampaio; Javed Khan; Katherine R Calvo; Jacob E Lemieux; Smita Y Patel; David M Frucht; Donald C Vinh; Roger D Auth; Alexandra F Freeman; Kenneth N Olivier; Gulbu Uzel; Christa S Zerbe; Christine Spalding; Stefania Pittaluga; Mark Raffeld; Douglas B Kuhns; Li Ding; Michelle L Paulson; Beatriz E Marciano; Juan C Gea-Banacloche; Jordan S Orange; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

3.  Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.

Authors:  Wolfgang Kern; Claudia Haferlach; Susanne Schnittger; Torsten Haferlach
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

4.  Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.

Authors:  Sergio Matarraz; Antonio López; Susana Barrena; Carlos Fernandez; Evan Jensen; Juan Flores-Montero; Ana Rasillo; José María Sayagues; Maria Luz Sánchez; Paloma Bárcena; Jesús María Hernandez-Rivas; Carlos Salvador; Nuria Fernandez-Mosteirín; Manuel Giralt; Luis Perdiguer; Paula Laranjeira; Artur Paiva; Alberto Orfao
Journal:  Cytometry B Clin Cytom       Date:  2010-05       Impact factor: 3.058

5.  Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.

Authors:  Elaine M Sloand; Colin O Wu; Peter Greenberg; Neal Young; John Barrett
Journal:  J Clin Oncol       Date:  2008-04-14       Impact factor: 44.544

6.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

Authors:  Donald C Vinh; Smita Y Patel; Gulbu Uzel; Victoria L Anderson; Alexandra F Freeman; Kenneth N Olivier; Christine Spalding; Stephen Hughes; Stefania Pittaluga; Mark Raffeld; Lynn R Sorbara; Houda Z Elloumi; Douglas B Kuhns; Maria L Turner; Edward W Cowen; Danielle Fink; Debra Long-Priel; Amy P Hsu; Li Ding; Michelle L Paulson; Adeline R Whitney; Elizabeth P Sampaio; David M Frucht; Frank R DeLeo; Steven M Holland
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

7.  Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?

Authors:  Marinella Veltroni; Laura Sainati; Marco Zecca; Susanna Fenu; Gloria Tridello; Anna Maria Testi; Alessandra Di Cesare Merlone; Barbara Buldini; Anna Leszl; Luca Lo Nigro; Daniela Longoni; Gabriella Bernini; Giuseppe Basso
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

8.  Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

Authors:  Kiyoyuki Ogata; Matteo G Della Porta; Luca Malcovati; Cristina Picone; Norio Yokose; Akira Matsuda; Taishi Yamashita; Hideto Tamura; Junichi Tsukada; Kazuo Dan
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

9.  T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.

Authors:  A C H de Vries; A W Langerak; B Verhaaf; C M Niemeyer; J Stary; K Schmiegelow; E R van Wering; C M Zwaan; A Beishuizen; R Pieters; M M van den Heuvel-Eibrink
Journal:  Leukemia       Date:  2008-03-06       Impact factor: 11.528

10.  Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment.

Authors:  Theresia M Westers; Canan Alhan; Martine E D Chamuleau; Maurice J D L van der Vorst; Corien Eeltink; Gert J Ossenkoppele; Arjan A van de Loosdrecht
Journal:  Blood       Date:  2009-12-28       Impact factor: 22.113

View more
  8 in total

1.  Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.

Authors:  Kasiani C Myers; Elissa Furutani; Edie Weller; Bradford Siegele; Ashley Galvin; Valerie Arsenault; Blanche P Alter; Farid Boulad; Carlos Bueso-Ramos; Lauri Burroughs; Paul Castillo; James Connelly; Stella M Davies; Courtney D DiNardo; Iftikhar Hanif; Richard H Ho; Nicole Karras; Michelle Manalang; Lisa J McReynolds; Taizo A Nakano; Grzegorz Nalepa; Maxim Norkin; Matthew J Oberley; Etan Orgel; Yves D Pastore; Joseph Rosenthal; Kelly Walkovich; Jordan Larson; Maggie Malsch; M Tarek Elghetany; Mark D Fleming; Akiko Shimamura
Journal:  Lancet Haematol       Date:  2019-12-23       Impact factor: 18.959

Review 2.  Quantification and three-dimensional microanatomical organization of the bone marrow.

Authors:  Cesar Nombela-Arrieta; Markus G Manz
Journal:  Blood Adv       Date:  2017-02-14

3.  Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

Authors:  Michaela Nováková; Markéta Žaliová; Martina Suková; Marcin Wlodarski; Aleš Janda; Eva Froňková; Vít Campr; Kateřina Lejhancová; Ondřej Zapletal; Dagmar Pospíšilová; Zdeňka Černá; Tomáš Kuhn; Peter Švec; Vendula Pelková; Zuzana Zemanová; Gitte Kerndrup; Marry van den Heuvel-Eibrink; Vincent van der Velden; Charlotte Niemeyer; Tomáš Kalina; Jan Trka; Jan Starý; Ondřej Hrušák; Ester Mejstříková
Journal:  Haematologica       Date:  2016-03-24       Impact factor: 9.941

Review 4.  Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

Authors:  Anna Porwit
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

5.  Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.

Authors:  Prisca Theunissen; Ester Mejstrikova; Lukasz Sedek; Alita J van der Sluijs-Gelling; Giuseppe Gaipa; Marius Bartels; Elaine Sobral da Costa; Michaela Kotrová; Michaela Novakova; Edwin Sonneveld; Chiara Buracchi; Paola Bonaccorso; Elen Oliveira; Jeroen G Te Marvelde; Tomasz Szczepanski; Ludovic Lhermitte; Ondrej Hrusak; Quentin Lecrevisse; Georgiana Emilia Grigore; Eva Froňková; Jan Trka; Monika Brüggemann; Alberto Orfao; Jacques J M van Dongen; Vincent H J van der Velden
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

6.  The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

Authors:  Yash B Shah; Salvatore F Priore; Yimei Li; Chi N Tang; Peter Nicholas; Peter Kurre; Timothy S Olson; Daria V Babushok
Journal:  Blood Adv       Date:  2021-08-24

7.  Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.

Authors:  Suiellen C Reis-Alves; Fabiola Traina; Konradin Metze; Irene Lorand-Metze
Journal:  Diagn Pathol       Date:  2015-04-29       Impact factor: 2.644

8.  Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry.

Authors:  Hadeer Mohamed Rasheed; Hanaa Mahmoud Donia; Eman Attia Nadwan; Zeinab Ibrahim Mourad; Nahla Farahat
Journal:  Oman Med J       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.